S. Fagiuoli - Concepedia

Author

S. Fagiuoli

Also Known As

DAVID H. VAN THIEL, Elke Erne, Fabiano DI MARCO, Fabio Ferla, Fagiuoli, S, Luca Miele, Luciano De Carlis, S FAGIUOLI, S Fagiuoli, S. FAGIUOLI

640

Publications

12.3K

Citations

H-Index

152

Concepts

All Affiliations

University of Padua Ospedale Papa Giovanni XXIII Istituti di Ricovero e Cura a Carattere Scientifico Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda University of Milan

About

S. Fagiuoli is an author at University of Padua specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	72	5.5K
2	Health Sciences	10	10	783
3	Public Health	10	10	882
4	Allergy	2	2	192
5	Engineering	1	1	28

S. Fagiuoli

141

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: A retrospective study Savino Bruno, Tommaso Stroffolini, Massimo Colombo, Hepatology	2007	602
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial Paolo Caraceni, Oliviero Riggio, Paolo Angeli, The Lancet HepatologyDecompensated CirrhosisLiver PhysiologyGastroenterologyAcute Liver Failure	2018	499
High rates of 30-day mortality in patients with cirrhosis and COVID-19 Massimo Iavarone, Roberta D’Ambrosio, Alessandro Soria, Journal of Hepatology HepatologyHigh RatesCovid-19 PandemicComplications Of Cirrhosis30-Day Mortality	2020	388
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study L Belli, Marina Berenguer, Paolo Angelo Cortesi, Journal of Hepatology TransplantationHepatologyHepatitis CViral HepatitisLiver Transplant Candidates	2016	339
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features Silvano Fasolato, Paolo Angeli, Lucia Dallagnese, Hepatology	2006	324
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial Vincenzo Mazzaferro, Davide Citterio, Sherrie Bhoori, The Lancet Oncology Surgical OncologyTransplantationHepatologyTumour DownstagingMedicine	2020	314
Association between reactive oxygen species and disease activity in chronic hepatitis C Nicola De Maria, Alessandra Colantonl, S. Fagiuoli, Free Radical Biology and Medicine InflammationHepatologyHepatitis CViral HepatitisLiver Physiology	1996	225
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC Andrea Notarpaolo, Richard Layese, Paolo Magistri, Journal of Hepatology Hcc RecurrenceHepatologyViral HepatitisViral Hepatitis-related CirrhosisHepatitis	2016	216
Response to interferon α therapy is influenced by the iron content of the liver David H. Van Thiel, Lois Friedlander, S. Fagiuoli, Journal of Hepatology InflammationHepatologyIron MetabolismLiver PhysiologyMedicine	1994	212
Percutaneous Ablation Procedures in Cirrhotic Patients With Hepatocellular Carcinoma Submitted to Liver Transplantation Maurizio Pompili, V.G. Mirante, G. F. Rondinara, Liver Transplantation	2005	195

Page 1